Literature DB >> 29234963

Financial Burden of Treatment of Transfusion Dependent Thalassemia.

Deepak Bansal1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29234963     DOI： 10.1007/s12098-017-2547-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study.

Authors:  Sidharth Totadri; Deepak Bansal; Prateek Bhatia; Savita V Attri; Amita Trehan; R K Marwaha
Journal:  Pediatr Blood Cancer       Date:  2015-03-28       Impact factor: 3.167

2.  MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population.

Authors:  Shantanu Mandal; Kushaljit Singh Sodhi; Deepak Bansal; Anindita Sinha; Anmol Bhatia; Amita Trehan; Niranjan Khandelwal
Journal:  Indian J Pediatr       Date:  2017-02-24       Impact factor: 1.967

3.  Socio-demographic Profile and Economic Burden of Treatment of Transfusion Dependent Thalassemia.

Authors:  Amita Moirangthem; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2017-11-09       Impact factor: 1.967

Review 4.  Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom.

Authors:  Diana Weidlich; Panos Kefalas; Julian F Guest
Journal:  Transfusion       Date:  2016-04-04       Impact factor: 3.157

Review 5.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

6.  Economic Burden of Thalassemia Major in Iran, 2015.

Authors:  Firooz Esmaeilzadeh; Azita Azarkeivan; Sara Emamgholipour; Ali Akbari Sari; Mehdi Yaseri; Batoul Ahmadi; Mohtasham Ghaffari
Journal:  J Res Health Sci       Date:  2016
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.